These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prognostic value of [ Stolzenburg A; Lückerath K; Samnick S; Speer M; Kneer K; Schmid JS; Grigoleit GU; Hofmann S; Beer AJ; Bunjes D; Knop S; Buck AK; Einsele H; Lapa C Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1694-1704. PubMed ID: 29610955 [TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study. Fonti R; Pace L; Cerchione C; Catalano L; Salvatore B; De Luca S; Pane F; Salvatore M; Del Vecchio S Clin Nucl Med; 2015 Apr; 40(4):303-8. PubMed ID: 25608167 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Baseline Moon SH; Choi WH; Yoo IR; Lee SJ; Paeng JC; Jeong SY; Lee SW; Kim K; Choi JY Korean J Radiol; 2018; 19(3):481-488. PubMed ID: 29713226 [TBL] [Abstract][Full Text] [Related]
7. Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On Cho HJ; Baek DW; Kim JH; Lee J; Chung YK; Jung SH; Song GY; Ahn SY; Ahn JS; Yang DH; Lee JJ; Kim HJ; Hong CM; Jeong SY; Min JJ; Sohn SK; Moon JH Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):113-120. PubMed ID: 34598908 [TBL] [Abstract][Full Text] [Related]
11. ¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders. Dammacco F; Rubini G; Ferrari C; Vacca A; Racanelli V Clin Exp Med; 2015 Feb; 15(1):1-18. PubMed ID: 25218739 [TBL] [Abstract][Full Text] [Related]
12. Interim PET Analysis in First-Line Therapy of Multiple Myeloma: Prognostic Value of ΔSUVmax in the FDG-Avid Patients of the IMAJEM Study. Bailly C; Carlier T; Jamet B; Eugene T; Touzeau C; Attal M; Hulin C; Facon T; Leleu X; Perrot A; Garderet L; Macro M; Caillot D; Moreau P; Kraeber-Bodéré F; Bodet-Milin C Clin Cancer Res; 2018 Nov; 24(21):5219-5224. PubMed ID: 30068709 [No Abstract] [Full Text] [Related]
13. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Zamagni E; Nanni C; Patriarca F; Englaro E; Castellucci P; Geatti O; Tosi P; Tacchetti P; Cangini D; Perrone G; Ceccolini M; Brioli A; Buttignol S; Fanin R; Salizzoni E; Baccarani M; Fanti S; Cavo M Haematologica; 2007 Jan; 92(1):50-5. PubMed ID: 17229635 [TBL] [Abstract][Full Text] [Related]
18. Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results. Nanni C; Zamagni E; Farsad M; Castellucci P; Tosi P; Cangini D; Salizzoni E; Canini R; Cavo M; Fanti S Eur J Nucl Med Mol Imaging; 2006 May; 33(5):525-31. PubMed ID: 16453155 [TBL] [Abstract][Full Text] [Related]
19. Role of Cavo M; Terpos E; Nanni C; Moreau P; Lentzsch S; Zweegman S; Hillengass J; Engelhardt M; Usmani SZ; Vesole DH; San-Miguel J; Kumar SK; Richardson PG; Mikhael JR; da Costa FL; Dimopoulos MA; Zingaretti C; Abildgaard N; Goldschmidt H; Orlowski RZ; Chng WJ; Einsele H; Lonial S; Barlogie B; Anderson KC; Rajkumar SV; Durie BGM; Zamagni E Lancet Oncol; 2017 Apr; 18(4):e206-e217. PubMed ID: 28368259 [TBL] [Abstract][Full Text] [Related]